S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Sports analytics may be outnumbered when it comes to artificial intelligence
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
What to watch for as China's major political meeting of the year gets underway
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
South Korean doctors hold massive anti-government rally over medical school recruitment plan
Former Bank of Beijing chairman under investigation, part of China's crackdown on corruption
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Sports analytics may be outnumbered when it comes to artificial intelligence
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
What to watch for as China's major political meeting of the year gets underway
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
South Korean doctors hold massive anti-government rally over medical school recruitment plan
Former Bank of Beijing chairman under investigation, part of China's crackdown on corruption
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Sports analytics may be outnumbered when it comes to artificial intelligence
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
What to watch for as China's major political meeting of the year gets underway
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
South Korean doctors hold massive anti-government rally over medical school recruitment plan
Former Bank of Beijing chairman under investigation, part of China's crackdown on corruption
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Sports analytics may be outnumbered when it comes to artificial intelligence
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
What to watch for as China's major political meeting of the year gets underway
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
South Korean doctors hold massive anti-government rally over medical school recruitment plan
Former Bank of Beijing chairman under investigation, part of China's crackdown on corruption
NYSE:OMI

Owens & Minor (OMI) Stock Price, News & Analysis

$24.64
+0.31 (+1.27%)
(As of 03/1/2024 ET)
Today's Range
$24.07
$24.88
50-Day Range
$18.44
$25.04
52-Week Range
$11.79
$25.39
Volume
575,270 shs
Average Volume
740,580 shs
Market Capitalization
$1.89 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$22.29

Owens & Minor MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
9.6% Downside
$22.29 Price Target
Short Interest
Bearish
8.21% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.52
Upright™ Environmental Score
News Sentiment
0.85mentions of Owens & Minor in the last 14 days
Based on 20 Articles This Week
Insider Trading
Selling Shares
$492,300 Sold Last Quarter
Proj. Earnings Growth
25.97%
From $1.54 to $1.94 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.27 out of 5 stars

Medical Sector

159th out of 950 stocks

Medical & Hospital Equipment Industry

2nd out of 3 stocks

OMI stock logo

About Owens & Minor Stock (NYSE:OMI)

Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates in two segments, Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, including supplier management, analytics, inventory management, and clinical supply management; and various programs to provide outsourced logistics and marketing solutions to its suppliers. The Patient Direct segment provides products and services for in-home care and delivery across diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment. This segment supplies a range of other home medical equipment, patient care products, including ostomy, wound care, urology, incontinence and other products and services. It serves multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians' practices, and networks of hospitals directly, as well as indirectly through third-party distributors. The company was founded in 1882 and is headquartered in Richmond, Virginia.

OMI Stock Price History

OMI Stock News Headlines

This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Owens & Minor (NYSE:OMI) Now Covered by Analysts at SVB Leerink
Owens & Minor (NYSE:OMI) Sets New 1-Year High at $23.91
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Owens & Minor (NYSE:OMI) Price Target Raised to $23.00 at Barclays
Owens & Minor (NYSE:OMI) Upgraded to "Buy" by StockNews.com
Q4 2023 Owens & Minor Inc Earnings Call
Owens & Minor Shares Advance After 4Q Earnings, Outlook
Recap: Owens & Minor Q4 Earnings
Owens & Minor Q4 Adj. Net Income Rises - Quick Facts
Owens & Minor (OMI) Q4 Earnings Surpass Estimates
A Preview Of Owens & Minor's Earnings
See More Headlines
Receive OMI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Owens & Minor and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/20/2024
Today
3/03/2024
Next Earnings (Estimated)
5/03/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medical & hospital equipment
Sub-Industry
Health Care Distributors
CUSIP
69073210
Employees
13,700
Year Founded
1882

Price Target and Rating

Average Stock Price Target
$22.29
High Stock Price Target
$26.00
Low Stock Price Target
$19.00
Potential Upside/Downside
-9.6%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
7 Analysts

Profitability

Net Income
$-41,300,000.00
Pretax Margin
-0.53%

Debt

Sales & Book Value

Annual Sales
$10.33 billion
Cash Flow
$5.13 per share
Book Value
$12.06 per share

Miscellaneous

Free Float
73,847,000
Market Cap
$1.89 billion
Optionable
Optionable
Beta
0.41

Social Links

Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report














OMI Stock Analysis - Frequently Asked Questions

Should I buy or sell Owens & Minor stock right now?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Owens & Minor in the last twelve months. There are currently 1 sell rating, 5 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" OMI shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OMI, but not buy additional shares or sell existing shares.
View OMI analyst ratings
or view top-rated stocks.

What is Owens & Minor's stock price target for 2024?

7 Wall Street research analysts have issued 1-year target prices for Owens & Minor's stock. Their OMI share price targets range from $19.00 to $26.00. On average, they anticipate the company's stock price to reach $22.29 in the next twelve months. This suggests that the stock has a possible downside of 9.6%.
View analysts price targets for OMI
or view top-rated stocks among Wall Street analysts.

How have OMI shares performed in 2024?

Owens & Minor's stock was trading at $19.27 at the beginning of the year. Since then, OMI stock has increased by 27.9% and is now trading at $24.64.
View the best growth stocks for 2024 here
.

When is Owens & Minor's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, May 3rd 2024.
View our OMI earnings forecast
.

How were Owens & Minor's earnings last quarter?

Owens & Minor, Inc. (NYSE:OMI) issued its quarterly earnings results on Tuesday, February, 20th. The company reported $0.69 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.66 by $0.03. The business had revenue of $2.66 billion for the quarter, compared to analysts' expectations of $2.67 billion. Owens & Minor had a positive trailing twelve-month return on equity of 11.62% and a negative net margin of 0.40%. The firm's revenue was up 4.1% compared to the same quarter last year. During the same quarter last year, the firm earned $0.28 EPS.

What ETFs hold Owens & Minor's stock?
What guidance has Owens & Minor issued on next quarter's earnings?

Owens & Minor issued an update on its FY24 earnings guidance on Tuesday, February, 20th. The company provided EPS guidance of $1.40-$1.70 for the period, compared to the consensus estimate of $1.58. The company issued revenue guidance of $10.5-$10.9 billion, compared to the consensus revenue estimate of $10.67 billion.

What is Ed Pesicka's approval rating as Owens & Minor's CEO?

36 employees have rated Owens & Minor Chief Executive Officer Ed Pesicka on Glassdoor.com. Ed Pesicka has an approval rating of 65% among the company's employees.

What other stocks do shareholders of Owens & Minor own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Owens & Minor investors own include Advanced Micro Devices (AMD), AT&T (T), Pfizer (PFE), AbbVie (ABBV), Micron Technology (MU), NVIDIA (NVDA), Applied Materials (AMAT), Enterprise Products Partners (EPD), Johnson & Johnson (JNJ) and Cisco Systems (CSCO).

Who are Owens & Minor's major shareholders?

Owens & Minor's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (11.23%), Dimensional Fund Advisors LP (5.50%), Nuveen Asset Management LLC (1.44%), Northern Trust Corp (1.19%), Charles Schwab Investment Management Inc. (1.08%) and Voloridge Investment Management LLC (0.82%). Insiders that own company stock include Alexander J Bruni, Andrew G Long, Andrew G Long, Brad George, Christopher M Lowery, Edward A Pesicka, Gwendolyn M Bingham, Heath H Galloway, Jeffrey T Jochims, Jeffrey T Jochims, Jonathan A Leon, Lawrence Lacerte, Louis Emmanuel Castro, Mark P Zacur, Michael Wayne Lowry, Nicholas J Pace, Perry A Bernocchi, Robert J Henkel, Robert Weideman and Shana Carol Neal.
View institutional ownership trends
.

How do I buy shares of Owens & Minor?

Shares of OMI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does Owens & Minor have any subsidiaries?
The following companies are subsidiares of Owens & Minor: 500 Expressway Drive South LLC, 5nq, AVID Medical Inc., Access Diabetic Supply, Access Diabetic Supply L.L.C., Access Respiratory Supply Inc, Arabian Medical Products Manufacturing Company, ArcRoyal, ArcRoyal Holdings Unlimited Company, ArcRoyal Unlimited Company, Barista Acquisition I LLC, Barista Acquisition II LLC, Byram Healthcare Centers, Byram Healthcare Centers Inc., Byram Holdings I Inc., Clinical Care Services L.L.C., Cyrus Medical Systems, Diabetes Specialty Center L.L.C., Fusion 5 Inc., Halyard Health - S&IP, Halyard Malaysia SND BHD, Halyard North Carolina LLC, HealthCare Logistics Services, Key Diabetes Supply Co., La Ada de Acuna S. de R.L. de C.V., MAI Acquisition Corp., MIRA Medsource (Malaysia) SDN. BHD., McKesson's Acute-Care Medical, Medegen Newco LLC, Medical Action Industries, Medical Action Industries Inc., Medical Supply Group Inc., Mira MEDsource (Shanghai) Co. LTD, Mira MEDsource Holding Company Limited, Movianto, Nalvest Limited, O and M Halyard South Africa Pty Ltd, O&M Brasil Consultoria Ltda, O&M Byram Holdings GP, O&M Funding LLC, O&M Halyard Australia PTY LTD, O&M Halyard Belgium, O&M Halyard Canada Inc., O&M Halyard France, O&M Halyard Germany GmbH, O&M Halyard Health India Private Limited, O&M Halyard Honduras S.A. de C.V., O&M Halyard Inc., O&M Halyard International Unlimited Company, O&M Halyard Ireland Limited, O&M Halyard Japan GK, O&M Halyard Mexico S. de R.L. de C.V., O&M Halyard Netherlands B.V., O&M Halyard Singapore PTE Ltd, O&M Halyard UK Limited, O&M Healthcare Italia S.R.L., O&M International Healthcare C.V., O&M Worldwide LLC, OMSolutions International Inc., Owens & Minor Canada Inc., Owens & Minor Distribution Inc., Owens & Minor Global Resources LLC, Owens & Minor Global Services Unlimited Company, Owens & Minor Healthcare Supply Inc., Owens & Minor Inc., Owens & Minor Inc. Executive Deferred Compensation Trust, Owens & Minor International Logistics Inc., Owens & Minor International Unlimited Company, Owens & Minor Ireland Unlimited Company, Owens & Minor Jersey Holdings Limited, Owens & Minor Jersey Unlimited, Owens & Minor Medical Inc., Safeskin Medical & Scientific (Thailand) Ltd., Stuart Medical, and The Burrows Company.
Read More
This page (NYSE:OMI) was last updated on 3/3/2024 by MarketBeat.com Staff

From Our Partners